Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003312603 | SCV004011533 | uncertain significance | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | GABRA2: PM2, PP2, PP3 |
Institute of Human Genetics, |
RCV003883213 | SCV004697504 | pathogenic | Developmental and epileptic encephalopathy, 78 | 2024-02-27 | criteria provided, single submitter | clinical testing | This variant has been identified by standard clinical testing. Selected ACMG criteria: Pathogenic (III):PP3;PP2;PM2;PM1;PS2 |